4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. (Q53636905)

16 May 2018

title

4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. (English)

1 reference

16 May 2018

author name string

Michael W Munks

1

1 reference

16 May 2018

Dan V Mourich

2

1 reference

16 May 2018

Robert S Mittler

3

1 reference

16 May 2018

Andrew D Weinberg

4

1 reference

16 May 2018

Ann B Hill

5

1 reference

16 May 2018

publication date

1 August 2004

1 reference

16 May 2018

published in

Immunology

1 reference

16 May 2018

volume

112

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

page(s)

559-566

1 reference

16 May 2018

Development of a DNA-MVA/HIVA vaccine for Kenya

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01917.X

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

21 January 2018

1 reference

12 December 2020

4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses

1 reference

12 December 2020

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

12 December 2020

4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination

1 reference

12 December 2020

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

1 reference

12 December 2020

Cytokine, Chemokine, and Costimulatory Molecule Modulation to Enhance Efficacy of HIV Vaccines

1 reference

12 December 2020

Inducible T cell antigen 4-1BB. Analysis of expression and function

1 reference

12 December 2020

4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells

1 reference

12 December 2020

Functional analysis of T-cell antigen 4-1BB in activated intestinal intra-epithelial T lymphocytes

1 reference

12 December 2020

Antigen processing in vivo and the elicitation of primary CTL responses

1 reference

12 December 2020

Costimulation of CD28- T lymphocytes by 4-1BB ligand

1 reference

12 December 2020

Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death

1 reference

12 December 2020

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

12 December 2020

Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses

1 reference

12 December 2020

Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

1 reference

12 December 2020

Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal

1 reference

12 December 2020

Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.

1 reference

12 December 2020

10.1111/J.1365-2567.2004.01917.X

Identifiers

DOI

1 reference

16 May 2018

0 references

1 reference

16 May 2018